Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service

Aims Determine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately estimate the future burden of this specific and debilitating complication of diabetes. Methods A cross-sectional analysis of 91 393 persons...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	British journal of ophthalmology Ročník 99; číslo 1; s. 64 - 68
Hlavní autori:	Thomas, Rebecca L, Dunstan, Frank D, Luzio, Stephen D, Chowdhury, Sharmistha Roy, North, Rachel V, Hale, Sarah L, Gibbins, Robert L, Owens, David R
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England BMJ Publishing Group LTD 01.01.2015
Predmet:	Adolescent Adult Aged Blood pressure Child Consent Cross-Sectional Studies Diabetes Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 2 - complications Diabetic retinopathy Diabetic Retinopathy - classification Diabetic Retinopathy - diagnosis Diabetic Retinopathy - epidemiology Female Humans Male Mass Screening - methods Middle Aged National Health Programs - statistics & numerical data Odds Ratio Photography Prevalence Quality Risk Factors Severity of Illness Index Wales - epidemiology Young Adult Wales United Kingdom > UK Retina Epidemiology Public health
ISSN:	0007-1161, 1468-2079, 1468-2079
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Aims Determine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately estimate the future burden of this specific and debilitating complication of diabetes. Methods A cross-sectional analysis of 91 393 persons with diabetes, 5003 type 1 diabetes and 86 390 type 2 diabetes, at their first screening by the community based National Diabetic Retinopathy Screening Service for Wales from 2005 to 2009. Image capture used 2×45° digital images per eye following mydriasis, classified by qualified retinal graders with final grading based on the worst eye. Results The prevalence of any DR and sight-threatening DR in those with type 1 diabetes was 56.0% and 11.2%, respectively, and in type 2 diabetes was 30.3% and 2.9%, respectively. The presence of DR, non-sight-threatening and sight-threatening, was strongly associated with increasing duration of diabetes for either type 1 or type 2 diabetes and also associated with insulin therapy in those with type 2 diabetes. Conclusions Prevalence of DR within the largest reported community-based, quality assured, DR screening programme, was higher in persons with type 1 diabetes; however, the major burden is represented by type 2 diabetes which is 94% of the screened population.
AbstractList	AimsDetermine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately estimate the future burden of this specific and debilitating complication of diabetes.MethodsA cross-sectional analysis of 91393 persons with diabetes, 5003 type 1 diabetes and 86390 type 2 diabetes, at their first screening by the community based National Diabetic Retinopathy Screening Service for Wales from 2005 to 2009. Image capture used 245 degree digital images per eye following mydriasis, classified by qualified retinal graders with final grading based on the worst eye.ResultsThe prevalence of any DR and sight-threatening DR in those with type 1 diabetes was 56.0% and 11.2%, respectively, and in type 2 diabetes was 30.3% and 2.9%, respectively. The presence of DR, non-sight-threatening and sight-threatening, was strongly associated with increasing duration of diabetes for either type 1 or type 2 diabetes and also associated with insulin therapy in those with type 2 diabetes.ConclusionsPrevalence of DR within the largest reported community-based, quality assured, DR screening programme, was higher in persons with type 1 diabetes; however, the major burden is represented by type 2 diabetes which is 94% of the screened population. Determine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately estimate the future burden of this specific and debilitating complication of diabetes. A cross-sectional analysis of 91,393 persons with diabetes, 5003 type 1 diabetes and 86,390 type 2 diabetes, at their first screening by the community based National Diabetic Retinopathy Screening Service for Wales from 2005 to 2009. Image capture used 2×45° digital images per eye following mydriasis, classified by qualified retinal graders with final grading based on the worst eye. The prevalence of any DR and sight-threatening DR in those with type 1 diabetes was 56.0% and 11.2%, respectively, and in type 2 diabetes was 30.3% and 2.9%, respectively. The presence of DR, non-sight-threatening and sight-threatening, was strongly associated with increasing duration of diabetes for either type 1 or type 2 diabetes and also associated with insulin therapy in those with type 2 diabetes. Prevalence of DR within the largest reported community-based, quality assured, DR screening programme, was higher in persons with type 1 diabetes; however, the major burden is represented by type 2 diabetes which is 94% of the screened population. Aims Determine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately estimate the future burden of this specific and debilitating complication of diabetes. Methods A cross-sectional analysis of 91 393 persons with diabetes, 5003 type 1 diabetes and 86 390 type 2 diabetes, at their first screening by the community based National Diabetic Retinopathy Screening Service for Wales from 2005 to 2009. Image capture used 2×45° digital images per eye following mydriasis, classified by qualified retinal graders with final grading based on the worst eye. Results The prevalence of any DR and sight-threatening DR in those with type 1 diabetes was 56.0% and 11.2%, respectively, and in type 2 diabetes was 30.3% and 2.9%, respectively. The presence of DR, non-sight-threatening and sight-threatening, was strongly associated with increasing duration of diabetes for either type 1 or type 2 diabetes and also associated with insulin therapy in those with type 2 diabetes. Conclusions Prevalence of DR within the largest reported community-based, quality assured, DR screening programme, was higher in persons with type 1 diabetes; however, the major burden is represented by type 2 diabetes which is 94% of the screened population. Determine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately estimate the future burden of this specific and debilitating complication of diabetes.AIMSDetermine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately estimate the future burden of this specific and debilitating complication of diabetes.A cross-sectional analysis of 91,393 persons with diabetes, 5003 type 1 diabetes and 86,390 type 2 diabetes, at their first screening by the community based National Diabetic Retinopathy Screening Service for Wales from 2005 to 2009. Image capture used 2×45° digital images per eye following mydriasis, classified by qualified retinal graders with final grading based on the worst eye.METHODSA cross-sectional analysis of 91,393 persons with diabetes, 5003 type 1 diabetes and 86,390 type 2 diabetes, at their first screening by the community based National Diabetic Retinopathy Screening Service for Wales from 2005 to 2009. Image capture used 2×45° digital images per eye following mydriasis, classified by qualified retinal graders with final grading based on the worst eye.The prevalence of any DR and sight-threatening DR in those with type 1 diabetes was 56.0% and 11.2%, respectively, and in type 2 diabetes was 30.3% and 2.9%, respectively. The presence of DR, non-sight-threatening and sight-threatening, was strongly associated with increasing duration of diabetes for either type 1 or type 2 diabetes and also associated with insulin therapy in those with type 2 diabetes.RESULTSThe prevalence of any DR and sight-threatening DR in those with type 1 diabetes was 56.0% and 11.2%, respectively, and in type 2 diabetes was 30.3% and 2.9%, respectively. The presence of DR, non-sight-threatening and sight-threatening, was strongly associated with increasing duration of diabetes for either type 1 or type 2 diabetes and also associated with insulin therapy in those with type 2 diabetes.Prevalence of DR within the largest reported community-based, quality assured, DR screening programme, was higher in persons with type 1 diabetes; however, the major burden is represented by type 2 diabetes which is 94% of the screened population.CONCLUSIONSPrevalence of DR within the largest reported community-based, quality assured, DR screening programme, was higher in persons with type 1 diabetes; however, the major burden is represented by type 2 diabetes which is 94% of the screened population. Aims Determine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately estimate the future burden of this specific and debilitating complication of diabetes. Methods A cross-sectional analysis of 91 393 persons with diabetes, 5003 type 1 diabetes and 86 390 type 2 diabetes, at their first screening by the community based National Diabetic Retinopathy Screening Service for Wales from 2005 to 2009. Image capture used 2x45° digital images per eye following mydriasis, classified by qualified retinal graders with final grading based on the worst eye. Results The prevalence of any DR and sight-threatening DR in those with type 1 diabetes was 56.0% and 11.2%, respectively, and in type 2 diabetes was 30.3% and 2.9%, respectively. The presence of DR, non-sight-threatening and sight-threatening, was strongly associated with increasing duration of diabetes for either type 1 or type 2 diabetes and also associated with insulin therapy in those with type 2 diabetes. Conclusions Prevalence of DR within the largest reported community-based, quality assured, DR screening programme, was higher in persons with type 1 diabetes; however, the major burden is represented by type 2 diabetes which is 94% of the screened population.
Author	Luzio, Stephen D North, Rachel V Dunstan, Frank D Hale, Sarah L Gibbins, Robert L Owens, David R Thomas, Rebecca L Chowdhury, Sharmistha Roy
Author_xml	– sequence: 1 givenname: Rebecca L surname: Thomas fullname: Thomas, Rebecca L email: owensdr@cardiff.ac.uk organization: Diabetes Research Group, Swansea University, Swansea, Wales, UK – sequence: 2 givenname: Frank D surname: Dunstan fullname: Dunstan, Frank D email: owensdr@cardiff.ac.uk organization: Institute of Primary Care and Public Health, Cardiff University, Cardiff, Wales, UK – sequence: 3 givenname: Stephen D surname: Luzio fullname: Luzio, Stephen D email: owensdr@cardiff.ac.uk organization: Diabetes Research Group, Swansea University, Swansea, Wales, UK – sequence: 4 givenname: Sharmistha Roy surname: Chowdhury fullname: Chowdhury, Sharmistha Roy email: owensdr@cardiff.ac.uk organization: Institute of Molecular and Experimental Medicine, Cardiff University, Cardiff, Wales, UK – sequence: 5 givenname: Rachel V surname: North fullname: North, Rachel V email: owensdr@cardiff.ac.uk organization: School of Optometry & Vision Sciences, Cardiff University, Cardiff, Wales, UK – sequence: 6 givenname: Sarah L surname: Hale fullname: Hale, Sarah L email: owensdr@cardiff.ac.uk organization: Department of Ophthalmology, Cardiff and Vale University Health Board, Cardiff, Wales, UK – sequence: 7 givenname: Robert L surname: Gibbins fullname: Gibbins, Robert L email: owensdr@cardiff.ac.uk organization: Retired GP, Powys, Wales, UK – sequence: 8 givenname: David R surname: Owens fullname: Owens, David R email: owensdr@cardiff.ac.uk organization: Diabetes Research Group, Swansea University, Swansea, Wales, UK
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/25091950$$D View this record in MEDLINE/PubMed
BookMark	eNqNkV1LBCEUhiWK2j7-Qgx0082UZxx1vAki-oKFuqirLgZ1ndZlRjd1i_59blsREdTNEQ_PecXzbKN1551BqAB8BEDYsZr5-TRNZT_4vqwwkJLgGgNfQyOoWZNbXKyjEcaYlwAMttB2jLN8rRjwTbRVUSxAUDxCD7fBPMveOG0K3xUTK5VJVhchV-fnMk1fixebptYVsnAyWe9k_zsWdTDGWfdYRBOerTa7aKOTfTR7H-cOur84vzu7Ksc3l9dnp-NSUcpSKUSlmqrrGKs114wowmWOZ42ZCKBCCdF0RMma56q6irCuYgJ0A1zhquaa7KDDVe48-KeFiakdbNSm76UzfhFbaIByLIigf6OMcMpqzEhGD36gM78I-feZ4rwRVDAQmdr_oBZqMJN2Huwgw2v7ueEMNCtABx9jMN0XArhdymy_y2yXMtuVzDx68mNU2_SuIAVp-_8EkFWAGmb_f_YNZoy70Q
CODEN	BJOPAL
CitedBy_id	crossref_primary_10_1007_s00417_020_04914_2 crossref_primary_10_1016_j_biopha_2024_116202 crossref_primary_10_3389_fnagi_2021_666495 crossref_primary_10_1016_j_jdiacomp_2017_04_010 crossref_primary_10_1186_s13020_016_0109_6 crossref_primary_10_1007_s12020_016_1097_0 crossref_primary_10_1007_s00103_020_03211_x crossref_primary_10_1016_j_ophtha_2018_11_016 crossref_primary_10_1016_j_diabres_2019_107840 crossref_primary_10_1111_jdi_13740 crossref_primary_10_1136_bmjopen_2021_050058 crossref_primary_10_3390_jpm15030106 crossref_primary_10_3389_fendo_2017_00302 crossref_primary_10_1136_bmjdrc_2023_003683 crossref_primary_10_1007_s11042_023_16236_6 crossref_primary_10_1038_s41433_020_01326_8 crossref_primary_10_1016_j_jcjo_2022_04_002 crossref_primary_10_1016_j_jdiacomp_2018_06_015 crossref_primary_10_1016_j_mce_2016_12_003 crossref_primary_10_1016_j_mvr_2023_104501 crossref_primary_10_1111_dme_14536 crossref_primary_10_1155_2021_2942197 crossref_primary_10_1007_s10792_021_02088_2 crossref_primary_10_3390_medicina56040164 crossref_primary_10_1001_jamaophthalmol_2017_5202 crossref_primary_10_1080_17425247_2025_2482049 crossref_primary_10_1186_s12916_021_01966_x crossref_primary_10_1016_j_ajo_2016_06_037 crossref_primary_10_1136_bmjopen_2016_014444 crossref_primary_10_3390_medicina60010118 crossref_primary_10_1136_bmjopen_2016_013199 crossref_primary_10_1038_s41598_024_59005_7 crossref_primary_10_1016_j_mvr_2021_104310 crossref_primary_10_3390_jpm11080740 crossref_primary_10_3390_cells11213362 crossref_primary_10_1080_14737167_2020_1782748 crossref_primary_10_2147_OPTH_S267521 crossref_primary_10_1136_bjophthalmol_2018_311924 crossref_primary_10_3390_diagnostics14202340 crossref_primary_10_1136_bmjopen_2016_015024 crossref_primary_10_1177_11786329251347684 crossref_primary_10_4239_wjd_v12_i7_939 crossref_primary_10_1016_j_ophtha_2017_12_034 crossref_primary_10_1136_bmjdrc_2020_001622 crossref_primary_10_12968_bjha_2016_10_12_584 crossref_primary_10_3390_healthcare9060745 crossref_primary_10_1111_aos_13449 crossref_primary_10_1111_dme_15164 crossref_primary_10_1007_s00125_020_05319_w crossref_primary_10_1038_s41433_019_0468_1 crossref_primary_10_1007_s11892_017_0928_6 crossref_primary_10_1111_aos_15184 crossref_primary_10_3390_nu14010084 crossref_primary_10_1002_edm2_197 crossref_primary_10_3390_ijms25042405 crossref_primary_10_1097_IAE_0000000000000937 crossref_primary_10_1016_j_ophtha_2016_10_031 crossref_primary_10_1038_s41420_025_02439_3 crossref_primary_10_1186_s40814_020_00608_y crossref_primary_10_3390_biomedicines12102346 crossref_primary_10_1007_s00417_021_05298_7 crossref_primary_10_1016_j_preteyeres_2015_08_001 crossref_primary_10_4103_0301_4738_178144 crossref_primary_10_7759_cureus_53586 crossref_primary_10_1186_s12913_018_3804_4 crossref_primary_10_1001_jamaophthalmol_2020_3190 crossref_primary_10_3389_fcvm_2022_900640 crossref_primary_10_1186_s12967_023_04783_3 crossref_primary_10_1177_00033197241263384 crossref_primary_10_1177_0969141316672687 crossref_primary_10_2337_dc18_0828 crossref_primary_10_1186_s40662_015_0026_2 crossref_primary_10_2337_dc22_0713 crossref_primary_10_1136_bjophthalmol_2020_317508 crossref_primary_10_1136_bmjopen_2019_035492 crossref_primary_10_3390_pharmaceutics14112330 crossref_primary_10_1109_ACCESS_2021_3074458 crossref_primary_10_1038_nrdp_2016_12 crossref_primary_10_3390_biomedicines11041222 crossref_primary_10_1016_j_aprim_2018_10_001 crossref_primary_10_3928_23258160_20240110_01 crossref_primary_10_3390_healthcare10071318 crossref_primary_10_1007_s12020_021_02871_2 crossref_primary_10_1136_bmjdrc_2016_000294 crossref_primary_10_1007_s00417_022_05745_z crossref_primary_10_1007_s10654_019_00560_z crossref_primary_10_1136_bjo_2023_324097 crossref_primary_10_1186_s12964_020_00698_4 crossref_primary_10_1007_s13410_019_00756_9 crossref_primary_10_3341_kjo_2021_0040 crossref_primary_10_1155_2022_9486679 crossref_primary_10_1111_aos_15684 crossref_primary_10_1371_journal_pone_0223788 crossref_primary_10_1111_aos_14348 crossref_primary_10_1016_j_survophthal_2022_01_009 crossref_primary_10_1136_bjophthalmol_2015_306727 crossref_primary_10_1186_s12906_017_1857_2 crossref_primary_10_1111_ceo_12757 crossref_primary_10_4103_IJO_IJO_399_23 crossref_primary_10_1177_1932296816629491 crossref_primary_10_1007_s10198_020_01191_y crossref_primary_10_1038_s41598_024_70175_2 crossref_primary_10_1038_eye_2016_294 crossref_primary_10_4103_HJOO_HJOO_10_24 crossref_primary_10_1111_aos_12952 crossref_primary_10_1002_jcp_29740 crossref_primary_10_21101_cejph_a5213 crossref_primary_10_22608_APO_2017511 crossref_primary_10_2147_OPTH_S509136 crossref_primary_10_1136_bjophthalmol_2015_307382 crossref_primary_10_1007_s12539_020_00391_7 crossref_primary_10_1002_hpm_2870 crossref_primary_10_1111_ceo_13728 crossref_primary_10_1007_s00125_020_05134_3 crossref_primary_10_3389_fcell_2025_1609928 crossref_primary_10_1167_iovs_61_6_49 crossref_primary_10_2147_OPTH_S447647 crossref_primary_10_3390_ijerph20075349
Cites_doi	10.1111/j.1755-3768.1994.tb02770.x 10.1038/sj.eye.6702767 10.1136/bmj.321.7258.412 10.1186/1471-2458-6-58 10.1007/s00417-011-1795-5 10.1016/j.diabet.2008.12.001 10.1111/j.1755-3768.1994.tb02741.x 10.2337/dc10-S011 10.1001/archopht.1984.01040030405011 10.2337/dc11-1909 10.1007/s00125-011-2198-1 10.1016/j.diabet.2008.07.002 10.1001/archopht.1984.01040030398010 10.1111/j.1464-5491.1991.tb01612.x 10.1046/j.1464-5491.2002.00854.x 10.1016/S0161-6420(13)38012-9 10.1001/archopht.116.3.297 10.1001/jama.2010.1111 10.1002/(SICI)1096-9136(1998110)15:3+3.3.CO;2-K 10.1046/j.1464-5491.19.s4.9.x 10.1136/bjo.2007.123810 10.1111/aos.12095 10.1542/peds.2005-0875 10.1007/s00125-012-2596-z 10.1258/jms.2008.008015 10.1111/j.1464-5491.2003.01077.x 10.1111/j.1464-5491.2009.02820.x 10.1016/S0008-4182(05)80091-2 10.1111/j.1464-5491.2003.01078.x 10.2146/ajhp070331 10.1046/j.1464-5491.2000.00353.x
ContentType	Journal Article
Copyright	Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright_xml	– notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. – notice: Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7TK
DOI	10.1136/bjophthalmol-2013-304017
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central BMJ Journals ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Neurosciences Abstracts
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) BMJ Journals Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic Neurosciences Abstracts
DatabaseTitleList	Neurosciences Abstracts MEDLINE MEDLINE - Academic ProQuest One Academic Middle East (New)
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1468-2079
EndPage	68
ExternalDocumentID	4012567441 25091950 10_1136_bjophthalmol_2013_304017 bjophthalmol
Genre	Research Support, Non-U.S. Gov't Journal Article
GeographicLocations	Wales United Kingdom--UK
GeographicLocations_xml	– name: Wales – name: United Kingdom--UK
GroupedDBID	--- -~X .55 .GJ .VT 0R~ 18M 23N 2WC 354 39C 3O- 4.4 40O 53G 5GY 5RE 5VS 6J9 7X7 7~S 88E 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAWJN ABAAH ABJNI ABKDF ABMQD ABTFR ABUWG ABVAJ ACCCW ACGFO ACGFS ACGTL ACHTP ACMFJ ACNCT ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADZCM AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN BAWUL BENPR BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DU5 E3Z EBS EJD F5P FYUFA H13 HAJ HMCUK HYE HZ~ IAO IEA IHR IOF ITC J5H KQ8 L7B M1P N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UAW UKHRP UYXKK V24 VM9 W8F WH7 WOQ X7M XOL YFH YQY ZGI AAFWJ AAYXX ACQHZ AERUA AFFHD CITATION PHGZM PJZUB PPXIY CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 7TK
ID	FETCH-LOGICAL-b556t-992b82ff664c7c63b37aabe68ed9159b998f3ba47f3bbf236f2691c817b0247c3
IEDL.DBID	7X7
ISICitedReferencesCount	145
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000346358000014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0007-1161 1468-2079
IngestDate	Thu Oct 02 11:41:51 EDT 2025 Thu Sep 04 18:20:10 EDT 2025 Tue Oct 07 07:14:55 EDT 2025 Thu Apr 03 07:02:43 EDT 2025 Tue Nov 18 20:04:00 EST 2025 Sat Nov 29 03:05:53 EST 2025 Thu Apr 24 23:05:17 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Retina Epidemiology Public health
Language	English
License	Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-b556t-992b82ff664c7c63b37aabe68ed9159b998f3ba47f3bbf236f2691c817b0247c3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
PMID	25091950
PQID	1778959619
PQPubID	2041039
PageCount	5
ParticipantIDs	proquest_miscellaneous_1815709395 proquest_miscellaneous_1637564063 proquest_journals_1778959619 pubmed_primary_25091950 crossref_primary_10_1136_bjophthalmol_2013_304017 crossref_citationtrail_10_1136_bjophthalmol_2013_304017 bmj_primary_10_1136_bjophthalmol_2013_304017
PublicationCentury	2000
PublicationDate	2015-01-01
PublicationDateYYYYMMDD	2015-01-01
PublicationDate_xml	– month: 01 year: 2015 text: 2015-01-01 day: 01
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England – name: London
PublicationTitle	British journal of ophthalmology
PublicationTitleAlternate	Br J Ophthalmol
PublicationYear	2015
Publisher	BMJ Publishing Group LTD
Publisher_xml	– name: BMJ Publishing Group LTD
References	Hammes, Kerner, Hofer 2011; 54 2010; 33 Bunce, Wormald 2006; 6 Beynat, Charles, Astruc 2009; 35 1991; 98 Olafsdottir, Anderson, Dedorsson 2014;; 92 Leese, Morris, Olson 2003; 20 2004 Kristinsson, Stefansson, Jonasson 1994; 72 Zhang, Saaddine, Chou 2010; 304 Looker, Nyangoma, Cromie 2012; 55 1991; 8 Bunce, Wormald 2008; 22 Lueder, Silverstein 2005; 116 Bloomgarden 2007; 64 Chabouis, Berdugo, Meas 2009; 35 Buxton, Sulpher, Ferguson 1991; 8 Klein, Klein, Moss 1984; 102 Yau, Rogers, Kawasaki 2012; 35 Harding, Greenwood, Aldington 2003; 20 Olafsdottir, Stefansson 2007; 91 Adler, Stratton, Neil 2000; 321 Shirasawa, Arimura, Otsuka 2011; 249 Misra, Bachmann, Greenwood 2009; 26 Scanlon 2008; 15 Kohner, Aldington, Stratton 1998; 116 Garvican, Clowes, Gillow 2000; 17 Boucher, Nguyen, Angioi 2005; 40 Burnett, Hurwitz, Davey 1998; 15 Younis, Broadbent, James 2002; 19 Zhang (key-10.1136/bjophthalmol-2013-304017-8) 2010; 304 Lueder (key-10.1136/bjophthalmol-2013-304017-22) 2005; 116 National Institute for Clinical Excellence (key-10.1136/bjophthalmol-2013-304017-21) 2004 Garvican (key-10.1136/bjophthalmol-2013-304017-20) 2000; 17 Misra (key-10.1136/bjophthalmol-2013-304017-32) 2009; 26 Bunce (key-10.1136/bjophthalmol-2013-304017-6) 2008; 22 Olafsdottir (key-10.1136/bjophthalmol-2013-304017-2) 2014;; 92 Boucher (key-10.1136/bjophthalmol-2013-304017-14) 2005; 40 key-10.1136/bjophthalmol-2013-304017-30 Kohner (key-10.1136/bjophthalmol-2013-304017-4) 1998; 116 Yau (key-10.1136/bjophthalmol-2013-304017-27) 2012; 35 Burnett (key-10.1136/bjophthalmol-2013-304017-11) 1998; 15 Scanlon (key-10.1136/bjophthalmol-2013-304017-17) 2008; 15 Early Treatment Diabetic Retinopathy Research Study Group (key-10.1136/bjophthalmol-2013-304017-28) 1991; 98 Chabouis (key-10.1136/bjophthalmol-2013-304017-19) 2009; 35 Klein (key-10.1136/bjophthalmol-2013-304017-36) 1984; 102 Gibbins (key-10.1136/bjophthalmol-2013-304017-26) 1999 UK prospective diabetes study group (UKPDS) (key-10.1136/bjophthalmol-2013-304017-38) 2000; 321 key-10.1136/bjophthalmol-2013-304017-24 American Diabetes Association (key-10.1136/bjophthalmol-2013-304017-35) 2010; 33 key-10.1136/bjophthalmol-2013-304017-23 Kristinsson (key-10.1136/bjophthalmol-2013-304017-34) 1994; 72 Buxton (key-10.1136/bjophthalmol-2013-304017-10) 1991; 8 key-10.1136/bjophthalmol-2013-304017-25 Leese (key-10.1136/bjophthalmol-2013-304017-13) 2003; 20 Klein (key-10.1136/bjophthalmol-2013-304017-37) 1984; 102 Younis (key-10.1136/bjophthalmol-2013-304017-33) 2002; 19 Bloomgarden (key-10.1136/bjophthalmol-2013-304017-16) 2007; 64 Bunce (key-10.1136/bjophthalmol-2013-304017-5) 2006; 6 Kristinsson (key-10.1136/bjophthalmol-2013-304017-31) 1994; 72 A protocol for screening for diabetic retinopathy in Europe (key-10.1136/bjophthalmol-2013-304017-9) 1991; 8 Harding (key-10.1136/bjophthalmol-2013-304017-29) 2003; 20 Looker (key-10.1136/bjophthalmol-2013-304017-3) 2012; 55 Olafsdottir (key-10.1136/bjophthalmol-2013-304017-15) 2007; 91 Younis (key-10.1136/bjophthalmol-2013-304017-12) 2002; 19 Beynat (key-10.1136/bjophthalmol-2013-304017-18) 2009; 35 Hammes (key-10.1136/bjophthalmol-2013-304017-1) 2011; 54 Shirasawa (key-10.1136/bjophthalmol-2013-304017-7) 2011; 249
References_xml	– volume: 19 start-page: 44 issue: (S4) year: 2002 article-title: Current status of screening for diabetic retinopathy in the UK publication-title: Diabetic Med – volume: 91 start-page: 1599 year: 2007 article-title: Biennial eye screening in diabetic patients without retinopathy. 10 year experience publication-title: Brit J Ophthalmol – volume: 98 start-page: 786 year: 1991 article-title: Grading diabetic retinopathy from stereoscopic color fundus photographs- an extension of the modified Airlie House Classification. ETDRS report number 10 publication-title: Ophthalmology – volume: 40 start-page: 734 year: 2005 article-title: Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine publication-title: Can J Ophthalmol – volume: 6 start-page: 58 year: 2006 article-title: Leading causes of certification for blindness and partial sight in England & Wales publication-title: BMC Public Health – volume: 15 start-page: 1 year: 2008 article-title: The English national screening programme for sight-threatening diabetic retinopathy publication-title: J Med Screen – volume: 35 start-page: 49 year: 2009 article-title: Screening for diabetic retinopathy in a rural French population with a mobile non-mydriatic camera publication-title: Diabetes Metab – volume: 304 start-page: 649 year: 2010 article-title: Prevalence of diabetic retinopathy in the United States, 2005–2008 publication-title: JAMA – volume: 8 start-page: 371 year: 1991 article-title: Screening for treatable diabetic retinopathy: a comparison of different methods publication-title: Diabetic Med – volume: 116 start-page: 297 year: 1998 article-title: United Kingdom prospective diabetes study, 30 diabetic retinopathy at diagnosis of non-insulin-dependant diabetes mellitus and associated risk factors publication-title: Arch of Ophthalmol – volume: 35 start-page: 556 year: 2012 article-title: Global prevalence and major risk factors of diabetic retinopathy publication-title: Diabetes Care – volume: 20 start-page: 965 year: 2003 article-title: Grading and disease management in national screening for diabetic retinopathy in England and Wales publication-title: Diabetic Med – volume: 26 start-page: 1040 year: 2009 article-title: Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme publication-title: Diabetic Med – volume: 64 start-page: S8 issue: (17 Suppl 12) year: 2007 article-title: Screening for and managing diabetic retinopathy: current approaches publication-title: Am J Health-Syst Ph – volume: 102 start-page: 527 year: 1984 article-title: The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years publication-title: Arch Ophthalmol – volume: 116 start-page: 270 year: 2005 article-title: Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus publication-title: Pediatrics – volume: 72 start-page: 72 year: 1994 article-title: Systematic screening for diabetic eye disease in insulin dependent diabetes publication-title: Acta Ophthalmologica – volume: 102 start-page: 520 year: 1984 article-title: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years publication-title: Arch Ophthalmol – volume: 15 start-page: S38 issue: (Suppl 3) year: 1998 article-title: The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study publication-title: Diabetic Med – volume: 17 start-page: 627 year: 2000 article-title: Preservation of sight in diabetes: developing a national risk reduction programme publication-title: Diabetic Med – volume: 55 start-page: 2335 year: 2012 article-title: Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland publication-title: Diabetologia – volume: 249 start-page: 1805 year: 2011 article-title: Intravitreous VEGF-A in eyes with massive vitreous hemorrhage publication-title: Graefe's Arch Clin Exp Ophthalmol – volume: 92 start-page: 133 year: 2014; article-title: The prevalence of retinopathy in subjects with and without type 2 diabetes mellitus publication-title: Acta Ophthalmologica – volume: 19 start-page: 1014 year: 2002 article-title: Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme publication-title: Diabetic Med – volume: 54 start-page: 1977 year: 2011 article-title: Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients publication-title: Diabetologia – year: 2004 article-title: Clinical Guideline 15: Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults – volume: 33 start-page: S11 issue: (Suppl 1) year: 2010 article-title: Clinical Practice Recommendations publication-title: Diabetes Care – volume: 8 start-page: 263 year: 1991 article-title: Retinopathy Working Party publication-title: Diabetic Med – volume: 321 start-page: 412 year: 2000 article-title: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes: prospective observational study publication-title: Brit Med J – volume: 35 start-page: 228 year: 2009 article-title: Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres publication-title: Diabetes Metab – volume: 20 start-page: 962 year: 2003 article-title: A national retinal screening programme for diabetes in Scotland publication-title: Diabetic Med – volume: 72 start-page: 341 year: 1994 article-title: Screening for eye disease in type 2 diabetes mellitus publication-title: Acta Ophthalmol Scand – volume: 22 start-page: 905 year: 2008 article-title: Causes of blind certifications in England and Wales: April 1999–2000 publication-title: Eye – volume: 72 start-page: 341 year: 1994 ident: key-10.1136/bjophthalmol-2013-304017-31 article-title: Screening for eye disease in type 2 diabetes mellitus publication-title: Acta Ophthalmol Scand doi: 10.1111/j.1755-3768.1994.tb02770.x – volume: 22 start-page: 905 year: 2008 ident: key-10.1136/bjophthalmol-2013-304017-6 article-title: Causes of blind certifications in England and Wales: April 1999–2000 publication-title: Eye doi: 10.1038/sj.eye.6702767 – volume: 321 start-page: 412 year: 2000 ident: key-10.1136/bjophthalmol-2013-304017-38 article-title: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes: prospective observational study publication-title: Brit Med J doi: 10.1136/bmj.321.7258.412 – volume: 6 start-page: 58 year: 2006 ident: key-10.1136/bjophthalmol-2013-304017-5 article-title: Leading causes of certification for blindness and partial sight in England & Wales publication-title: BMC Public Health doi: 10.1186/1471-2458-6-58 – volume: 249 start-page: 1805 year: 2011 ident: key-10.1136/bjophthalmol-2013-304017-7 article-title: Intravitreous VEGF-A in eyes with massive vitreous hemorrhage publication-title: Graefe's Arch Clin Exp Ophthalmol doi: 10.1007/s00417-011-1795-5 – volume: 35 start-page: 228 year: 2009 ident: key-10.1136/bjophthalmol-2013-304017-19 article-title: Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres publication-title: Diabetes Metab doi: 10.1016/j.diabet.2008.12.001 – volume: 72 start-page: 72 year: 1994 ident: key-10.1136/bjophthalmol-2013-304017-34 article-title: Systematic screening for diabetic eye disease in insulin dependent diabetes publication-title: Acta Ophthalmologica doi: 10.1111/j.1755-3768.1994.tb02741.x – volume: 33 start-page: S11 issue: (Suppl 1) year: 2010 ident: key-10.1136/bjophthalmol-2013-304017-35 article-title: Clinical Practice Recommendations publication-title: Diabetes Care doi: 10.2337/dc10-S011 – ident: key-10.1136/bjophthalmol-2013-304017-24 – volume: 102 start-page: 527 year: 1984 ident: key-10.1136/bjophthalmol-2013-304017-36 article-title: The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years publication-title: Arch Ophthalmol doi: 10.1001/archopht.1984.01040030405011 – volume: 35 start-page: 556 year: 2012 ident: key-10.1136/bjophthalmol-2013-304017-27 article-title: Global prevalence and major risk factors of diabetic retinopathy publication-title: Diabetes Care doi: 10.2337/dc11-1909 – volume: 54 start-page: 1977 year: 2011 ident: key-10.1136/bjophthalmol-2013-304017-1 article-title: Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients publication-title: Diabetologia doi: 10.1007/s00125-011-2198-1 – volume: 35 start-page: 49 year: 2009 ident: key-10.1136/bjophthalmol-2013-304017-18 article-title: Screening for diabetic retinopathy in a rural French population with a mobile non-mydriatic camera publication-title: Diabetes Metab doi: 10.1016/j.diabet.2008.07.002 – volume: 102 start-page: 520 year: 1984 ident: key-10.1136/bjophthalmol-2013-304017-37 article-title: The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years publication-title: Arch Ophthalmol doi: 10.1001/archopht.1984.01040030398010 – volume: 8 start-page: 371 year: 1991 ident: key-10.1136/bjophthalmol-2013-304017-10 article-title: Screening for treatable diabetic retinopathy: a comparison of different methods publication-title: Diabetic Med doi: 10.1111/j.1464-5491.1991.tb01612.x – volume: 19 start-page: 1014 year: 2002 ident: key-10.1136/bjophthalmol-2013-304017-33 article-title: Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme publication-title: Diabetic Med doi: 10.1046/j.1464-5491.2002.00854.x – volume: 98 start-page: 786 year: 1991 ident: key-10.1136/bjophthalmol-2013-304017-28 article-title: Grading diabetic retinopathy from stereoscopic color fundus photographs- an extension of the modified Airlie House Classification. ETDRS report number 10 publication-title: Ophthalmology doi: 10.1016/S0161-6420(13)38012-9 – volume: 116 start-page: 297 year: 1998 ident: key-10.1136/bjophthalmol-2013-304017-4 article-title: United Kingdom prospective diabetes study, 30 diabetic retinopathy at diagnosis of non-insulin-dependant diabetes mellitus and associated risk factors publication-title: Arch of Ophthalmol doi: 10.1001/archopht.116.3.297 – volume: 304 start-page: 649 year: 2010 ident: key-10.1136/bjophthalmol-2013-304017-8 article-title: Prevalence of diabetic retinopathy in the United States, 2005–2008 publication-title: JAMA doi: 10.1001/jama.2010.1111 – volume: 15 start-page: S38 issue: (Suppl 3) year: 1998 ident: key-10.1136/bjophthalmol-2013-304017-11 article-title: The implementation of prompted retinal screening for diabetic eye disease by accredited optometrists in an inner-city district of North London: a quality of care study publication-title: Diabetic Med doi: 10.1002/(SICI)1096-9136(1998110)15:3+3.3.CO;2-K – volume: 19 start-page: 44 issue: (S4) year: 2002 ident: key-10.1136/bjophthalmol-2013-304017-12 article-title: Current status of screening for diabetic retinopathy in the UK publication-title: Diabetic Med doi: 10.1046/j.1464-5491.19.s4.9.x – volume: 91 start-page: 1599 year: 2007 ident: key-10.1136/bjophthalmol-2013-304017-15 article-title: Biennial eye screening in diabetic patients without retinopathy. 10 year experience publication-title: Brit J Ophthalmol doi: 10.1136/bjo.2007.123810 – year: 2004 ident: key-10.1136/bjophthalmol-2013-304017-21 article-title: Clinical Guideline 15: Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults – volume: 92 start-page: 133 year: 2014; ident: key-10.1136/bjophthalmol-2013-304017-2 article-title: The prevalence of retinopathy in subjects with and without type 2 diabetes mellitus publication-title: Acta Ophthalmologica doi: 10.1111/aos.12095 – volume: 116 start-page: 270 year: 2005 ident: key-10.1136/bjophthalmol-2013-304017-22 article-title: Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus publication-title: Pediatrics doi: 10.1542/peds.2005-0875 – volume: 55 start-page: 2335 year: 2012 ident: key-10.1136/bjophthalmol-2013-304017-3 article-title: Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland publication-title: Diabetologia doi: 10.1007/s00125-012-2596-z – volume: 15 start-page: 1 year: 2008 ident: key-10.1136/bjophthalmol-2013-304017-17 article-title: The English national screening programme for sight-threatening diabetic retinopathy publication-title: J Med Screen doi: 10.1258/jms.2008.008015 – volume: 20 start-page: 965 year: 2003 ident: key-10.1136/bjophthalmol-2013-304017-29 article-title: Grading and disease management in national screening for diabetic retinopathy in England and Wales publication-title: Diabetic Med doi: 10.1111/j.1464-5491.2003.01077.x – volume-title: An evaluation of methods of community based screening and surveillance for diabetic retinopathy year: 1999 ident: key-10.1136/bjophthalmol-2013-304017-26 – ident: key-10.1136/bjophthalmol-2013-304017-23 – volume: 26 start-page: 1040 year: 2009 ident: key-10.1136/bjophthalmol-2013-304017-32 article-title: Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programme publication-title: Diabetic Med doi: 10.1111/j.1464-5491.2009.02820.x – ident: key-10.1136/bjophthalmol-2013-304017-25 – ident: key-10.1136/bjophthalmol-2013-304017-30 – volume: 40 start-page: 734 year: 2005 ident: key-10.1136/bjophthalmol-2013-304017-14 article-title: Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine publication-title: Can J Ophthalmol doi: 10.1016/S0008-4182(05)80091-2 – volume: 8 start-page: 263 year: 1991 ident: key-10.1136/bjophthalmol-2013-304017-9 article-title: Retinopathy Working Party publication-title: Diabetic Med – volume: 20 start-page: 962 year: 2003 ident: key-10.1136/bjophthalmol-2013-304017-13 article-title: A national retinal screening programme for diabetes in Scotland publication-title: Diabetic Med doi: 10.1111/j.1464-5491.2003.01078.x – volume: 64 start-page: S8 issue: (17 Suppl 12) year: 2007 ident: key-10.1136/bjophthalmol-2013-304017-16 article-title: Screening for and managing diabetic retinopathy: current approaches publication-title: Am J Health-Syst Ph doi: 10.2146/ajhp070331 – volume: 17 start-page: 627 year: 2000 ident: key-10.1136/bjophthalmol-2013-304017-20 article-title: Preservation of sight in diabetes: developing a national risk reduction programme publication-title: Diabetic Med doi: 10.1046/j.1464-5491.2000.00353.x
SSID	ssj0002617
Score	2.5234575
Snippet	Aims Determine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately... Determine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately... AimsDetermine the prevalence and severity of diabetic retinopathy (DR) and risk factors in a large community based screening programme, in order to accurately...
SourceID	proquest pubmed crossref bmj
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	64
SubjectTerms	Adolescent Adult Aged Blood pressure Child Consent Cross-Sectional Studies Diabetes Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 2 - complications Diabetic retinopathy Diabetic Retinopathy - classification Diabetic Retinopathy - diagnosis Diabetic Retinopathy - epidemiology Female Humans Male Mass Screening - methods Middle Aged National Health Programs - statistics & numerical data Odds Ratio Photography Prevalence Quality Risk Factors Severity of Illness Index Wales - epidemiology Young Adult
Title	Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service
URI	http://bjo.bmj.com/content/99/1/64.full https://www.ncbi.nlm.nih.gov/pubmed/25091950 https://www.proquest.com/docview/1778959619 https://www.proquest.com/docview/1637564063 https://www.proquest.com/docview/1815709395
Volume	99
WOSCitedRecordID	wos000346358000014&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1468-2079 dateEnd: 20250609 omitProxy: false ssIdentifier: ssj0002617 issn: 0007-1161 databaseCode: 7X7 dateStart: 19220101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1468-2079 dateEnd: 20250609 omitProxy: false ssIdentifier: ssj0002617 issn: 0007-1161 databaseCode: BENPR dateStart: 19220101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEB_6IdIXrR-tp23Zgo-GZr-zT6LS0gc9ilg48CHsbhJ65ZqcvWuh_70z-TgVtBR8CYHsJkNmduY3M7szAG9VUaLPFSjDmupEKbxz0ldJyaMvVCiCCG3J_M92PM4mE3fWB9wW_bbKQSe2irpoIsXIj7i1mdMO8f77-Y-EukZRdrVvobEOm9Q2m-TcTlYOV1ttvIO_NuEIbYadPNIchctmfrG88LOrZoaSwmWCfn1KbcvWw9Xln0bqH8iztUAnT_-X9m140mNP9qETlmewVtbP4fGXPrv-Ar5TPSffnkJiTcW6sOw0MjroWDfUu_iOUdx2WjPPhiji34ehMkIHGc0iW3TK6CWcnxx_-3Sa9M0XkqC1WSbOiZCJqjJGRRuNDNJ6fJ3JysIhBAroplUyeGXxGiohTSWM4zHjNqDZt1HuwEbd1OUrYEIUDnmfci-t8qLynLy-lBeKajsbNYJ3-M_zeVdeI2_dEmny31mUE4vyjkUjsANz8tgXMqd-GrMHzOSrmQ__2t7A07xf3ov8F0NHcLh6jAuTsi2-LpsbHGOk1QbxkrxnTMa1TZ10egS7nWytCBME5ZxOX99PwBvYQmp1FxXag43l9U25D4_i7XK6uD5o10N7zQ5g8-Px-OzrT3h3Fj4
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61BUEvPAtdKGAkuBE1fsSODwghoGrV7YpDkVbiEGzHUbfaJkt3C-qf4jcyjpMFJKh66YFLFCl2YsefZ74Z2zMAL0Tp0eayYYU1zRIh8E5zUyWeOlMKW1pm25D5QzUa5eOx_rgCP_qzMGFbZS8TW0FdNi74yLepUrnONPL9N7OvScgaFVZX-xQaERb7_vw7mmzz13vvcXxfMrbz4fDdbtJlFUhslslFojWzOasqKYVTTnLLlTHWy9yXGnW7Rfuj4tYIhVdbMS4rJjV1OVUW9ZlyHN-7CtdQjqtg7Knx0sBro5tHuq0SilSq3znE5bY9bmZHiyMzPWmmiEzKE47TJ6RJW7Unx38qxX8w3Vbj7dz-3_7VHbjVcWvyNk6Gu7Di63tw46DbPXAfPod4VaY9ZUWaikS388SRcJCzbkJu5nMS_NKTmhjSe0n_XgyFrffBpUTmUdhuwKcr6doDWKub2m8CYazUiO2UGq6EYZWhwapNaSlC7GopBvAKx7iYxfAhRWt2cVn8DokiQKKIkBiA6sFQuC5Qe8gXMr1ETbqsefmvbfUYKjrxNS9-AWgAz5ePUfCE1SRT--YMy0iuMol8kF9QJqeZSjXX2QAeRiwvG8YCVdVZ-ujiBjyDm7uHB8NiuDfafwzr2PIsesC2YG1xeuafwHX3bTGZnz5t5yKBL1cN6J-Mq3DE
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61W1RxobxZWsBIcCPa-BE7PqAKaFdULasVAqkSB2MnjrrVNlm6W1D_Gr-u4zwWkKDqpQcuUaTYiZN8nvlmPJ4BeCFyjzaXCyuscRIJgWea2yLyNLO5cLljrk6Zf6BGo_TwUI9X4Ge3FyaEVXYysRbUeZUFH_mAKpXqRCPfHxRtWMR4Z7g9-xaFClJhpbUrp9FAZN-f_0Dzbf56bwf_9UvGhruf3r2P2goDkUsSuYi0Zi5lRSGlyFQmuePKWudl6nONet6hLVJwZ4XCoysYlwWTmmYpVQ51m8o43ncV1hSSDNGDtbe7o_HHpR4Iuc4b8q0iisSqiyPicuCOq9nR4shOT6op4pTyiONkCkXTVt3J8Z8q8h-8t9Z_w43_-cvdhlst6yZvmmlyB1Z8eRfWP7RxBffgS8hkZev9V6QqSOOQnmQkbPEsq1C1-ZwEj_WkJJZ0_tO_N0Mx7H1wNpF5I4bvw-drebUH0Cur0j8CwliuEfUxtVwJywpLg70b01yErNZS9OEV_m8zaxKLmNog49L8Dg8T4GEaePRBdcAwWZvCPVQSmV6hJ132vPrTtjo8mVawzc0vMPXh-fIyiqSwzmRLX51hG8lVIpEp8kvapDRRseY66cPDBtfLgbFAYnUSP758AM9gHXFsDvZG-5twEweeNK6xLegtTs_8E7iRfV9M5qdP24lJ4Ot1I_oC7Zl65A
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+diabetic+retinopathy+within+a+national+diabetic+retinopathy+screening+service&rft.jtitle=British+journal+of+ophthalmology&rft.au=Thomas%2C+Rebecca+L&rft.au=Dunstan%2C+Frank+D&rft.au=Luzio%2C+Stephen+D&rft.au=Chowdhury%2C+Sharmistha+Roy&rft.date=2015-01-01&rft.issn=0007-1161&rft.volume=99&rft.issue=1&rft.spage=64&rft.epage=68&rft_id=info:doi/10.1136%2Fbjophthalmol-2013-304017&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1161&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1161&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1161&client=summon